Asia Pacific Smart Pills Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Smart Pills Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Smart Pills Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Smart Pills Market Regional Analysis

6.2 Asia Pacific Smart Pills Market Revenue 2019-2028 (US$ Million)

6.3 Asia Pacific Smart Pills Market Forecast Analysis

7. Asia Pacific Smart Pills Market Analysis – by Application

7.1 Capsule Endoscopy

7.1.1 Overview
7.1.2 Capsule Endoscopy: Asia Pacific Smart Pills Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Drug Delivery

7.2.1 Overview
7.2.2 Drug Delivery: Asia Pacific Smart Pills Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Patient Monitoring

7.3.1 Overview
7.3.2 Patient Monitoring: Asia Pacific Smart Pills Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Asia Pacific Smart Pills Market Analysis – by Disease Indication

8.1 Gastrointestinal Diseases

8.1.1 Overview
8.1.2 Gastrointestinal Diseases: Asia Pacific Smart Pills Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Neurological Disorders

8.2.1 Overview
8.2.2 Neurological Disorders: Asia Pacific Smart Pills Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Cancer

8.3.1 Overview
8.3.2 Cancer: Asia Pacific Smart Pills Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Inherited Disorders

8.4.1 Overview
8.4.2 Inherited Disorders: Asia Pacific Smart Pills Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.5 Other Disease Indications

8.5.1 Overview
8.5.2 Other Disease Indications: Asia Pacific Smart Pills Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Asia Pacific Smart Pills Market Analysis – by End User

9.1 Hospitals and Clinics

9.1.1 Overview
9.1.2 Hospitals and Clinics: Asia Pacific Smart Pills Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Research Institutes

9.2.1 Overview
9.2.2 Research Institutes: Asia Pacific Smart Pills Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Home Healthcare

9.3.1 Overview
9.3.2 Home Healthcare : Asia Pacific Smart Pills Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Asia Pacific Smart Pills Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific

10.2.1 Asia Pacific Smart Pills Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 Asia Pacific Smart Pills Market – Revenue and Forecast Analysis – by Country
10.2.1.1 China: Asia Pacific Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 China: Asia Pacific Smart Pills Market Breakdown, by Application
10.2.1.1.2 China: Asia Pacific Smart Pills Market Breakdown, by Disease Indication
10.2.1.1.3 China: Asia Pacific Smart Pills Market Breakdown, by End User

10.2.1.2 India: Asia Pacific Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 India: Asia Pacific Smart Pills Market Breakdown, by Application
10.2.1.2.2 India: Asia Pacific Smart Pills Market Breakdown, by Disease Indication
10.2.1.2.3 India: Asia Pacific Smart Pills Market Breakdown, by End User

10.2.1.3 Japan: Asia Pacific Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Japan: Asia Pacific Smart Pills Market Breakdown, by Application
10.2.1.3.2 Japan: Asia Pacific Smart Pills Market Breakdown, by Disease Indication
10.2.1.3.3 Japan: Asia Pacific Smart Pills Market Breakdown, by End User

10.2.1.4 Australia: Asia Pacific Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Australia: Asia Pacific Smart Pills Market Breakdown, by Application
10.2.1.4.2 Australia: Asia Pacific Smart Pills Market Breakdown, by Disease Indication
10.2.1.4.3 Australia: Asia Pacific Smart Pills Market Breakdown, by End User

10.2.1.5 Rest of Asia-Pacific : Asia Pacific Smart Pills Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Smart Pills Market Breakdown, by Application
10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Smart Pills Market Breakdown, by Disease Indication
10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Smart Pills Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Medtronic

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 PENTAX Medical

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Olympus Corporation

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Otsuka Holdings Co., Ltd.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 IntroMedic Co., Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 JINSHAN Science & Technology

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 RF Co., Ltd

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Asia Pacific Smart Pills Market

Analysis – by Application (Capsule Endoscopy, Drug Delivery, and Patient Monitoring), Disease Indication (Gastrointestinal Diseases, Neurological Disorders, Cancer, Inherited Disorders, and Other Disease Indications), and End User (Hospitals and Clinics, Research Institutes, and Home Healthcare)